Enhanced expression of vascular endothelial growth factor in metastatic melanoma
1997

VEGF Expression in Melanoma

Sample size: 55 publication Evidence: moderate

Author Information

Author(s): P Salven, P Heikkila, H Joensuu

Primary Institution: Helsinki University Central Hospital

Hypothesis

The study investigates the expression of VEGF in normal dermis, naevocellular naevi, and in primary and metastatic melanoma.

Conclusion

VEGF is up-regulated during melanoma progression and may contribute to the disease's progression.

Supporting Evidence

  • VEGF was detected in 91% of melanoma metastases but only 32% of primary melanomas.
  • A high number of VEGF-expressing inflammatory cells was associated with high VEGF expression in melanoma cells.
  • VEGF expression was not associated with overall survival in the studied patient population.

Takeaway

This study found that a protein called VEGF is more common in advanced melanoma than in early stages, which might help the cancer grow.

Methodology

The study used immunohistochemistry to assess VEGF expression in tissue samples from melanoma patients.

Limitations

The study's findings may not be generalizable beyond the specific patient population studied.

Participant Demographics

The study included 55 patients with malignant melanoma, 20 males and 13 females, aged 30 to 84 years.

Statistical Information

P-Value

p<0.0001; p=0.003

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication